Insider Stock Trading History of Krishnan Krish S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Krishnan Krish S since year 2005. The trader's CIK number is 1298709. At the time of this reporting, Krishnan Krish S is the President and CEO of Krystal Biotech, Inc. . (stock ticker symbol KRYS). See this page for all insider trading activities at Krystal Biotech, Inc. .

Note that in the past Krishnan Krish S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Krishnan Krish S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-22 KRYS Krystal Biotech, Inc. Buy 100,000 10.00 1,000,000
2016-01-28 XON Intrexon Corp Option Ex 14,657 6.88 100,840
2016-01-29 XON Intrexon Corp Option Ex 14,657 6.88 100,840
2015-12-02 XON Intrexon Corp Sale 20,000 35.91 718,259
2015-12-04 XON Intrexon Corp Sale 900 30.12 27,110
2015-05-18 XON Intrexon Corp Option Ex 84,000 7.12 598,080
2014-05-09 XON Intrexon Corp Buy 20,900 14.21 297,030
2006-11-09 NRPH New River Pharmaceuticals Inc Option Ex 59,000 2.62 154,875
2006-11-09 NRPH New River Pharmaceuticals Inc Sale 54,783 49.01 2,684,914
2006-11-10 NRPH New River Pharmaceuticals Inc Sale 35,217 48.23 1,698,480
2006-10-25 NRPH New River Pharmaceuticals Inc Option Ex 63,900 12.00 766,800
2006-03-20 NRPH New River Pharmaceuticals Inc Option Ex 30,000 1.25 37,500
2006-03-20 NRPH New River Pharmaceuticals Inc Sale 30,000 30.86 925,710
2006-02-13 NRPH New River Pharmaceuticals Inc Option Ex 17,464 1.25 21,830
2006-02-14 NRPH New River Pharmaceuticals Inc Option Ex 82,536 2.62 216,657
2006-02-13 NRPH New River Pharmaceuticals Inc Sale 17,464 30.12 525,945
2006-02-14 NRPH New River Pharmaceuticals Inc Sale 82,536 30.00 2,476,080
2005-08-19 NRPH New River Pharmaceuticals Inc Sale 5,000 36.95 184,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krishnan Krish S (President and CEO of Krystal Biotech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.